Improved individual and population-level HbA1c estimation using CGM data and patient characteristics

Estimation of Hemoglobin A1c from Continuous Glucose Monitoring Data in Individuals with Type 1 Diabetes: Is Time in Range All We Need?

(2020) Chiara Fabris et al.   Diabetes Technology & Therapeutics

Results of a Study Comparing Glycated Albumin to Other Glycemic Indices

(2019) Cyrus V Desouza et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Flexible Lifestyles Empowering Change (FLEX) Intervention Trial for Adolescents with Type 1 Diabetes—Primary and Secondary Outcomes

(2018) ELIZABETH J. MAYER-DAVIS et al.   DIABETES

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring

(2018) Richard M. Bergenstal et al.   DIABETES CARE

GLYCATED ALBUMIN AT 4 WEEKS CORRELATES WITH A1C LEVELS AT 12 WEEKS AND REFLECTS SHORT-TERM GLUCOSE FLUCTUATIONS

(2015) Cyrus V. Desouza et al.   Endocrine Practice

A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Metformin Therapy in Overweight/Obese Youth with Type 1 Diabetes

(2015) Benjamin Udoka Nwosu et al.   PLoS One

Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c

(2008) R. M. Cohen et al.   BLOOD

JDRF Randomized Clinical Trial to Assess the Efficacy of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes: Research Design and Methods

(2008)   Diabetes Technology & Therapeutics